Solara Active Pharma Sciences (Solara) has successfully completed EU GMP Inspection, carried out jointly by the State Institute for Drug Control (SUKL), Ministry of Health of the Czech Republic and National Authority of Medicines and Health Products (INFARMED), Portugal from February 07, 2023 to February 9, 2023, at the multi-product manufacturing facility at Cuddalore.
At the end of the inspection, it is concluded that the Quality Systems followed at Cuddalore site is Compliant to the EU GMP Standards. This Cuddalore facility has also successfully completed the inspection carried out by the World Health Organization (WHO) between January 23, 2023 to January 26, 2023.
Solara Active Pharma Sciences is a young, dynamic, entrepreneurial and customer oriented API manufacturer.
